The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A single institution real-world disease free survival analysis of adjuvant capecitabine in TNBC patients with residual disease following neoadjuvant chemotherapy.
 
Terrence Jones
No Relationships to Disclose
 
Victoria Beard
No Relationships to Disclose
 
Sidharth Mahajan
No Relationships to Disclose
 
Amit L Jain
No Relationships to Disclose
 
Leonard Jefferson Harris
No Relationships to Disclose
 
Emily McCollum Miller
No Relationships to Disclose
 
Jim Wan
No Relationships to Disclose
 
Patricia Goedecke
No Relationships to Disclose
 
Gregory A. Vidal
Employment - Novartis (I)
Stock and Other Ownership Interests - Oncodisc
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo; bioTheranostics; Genentech; Immunomedics; Lilly; Myriad Genetics; Novartis; Puma Biotechnology
Speakers' Bureau - Lilly
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb; Celcuity; Daiichi Sankyo; EMD Serono; Genentech/Roche; Lilly; Myriad Genetics; Natera; Puma Biotechnology; Tesaro